MedTrace Logo

Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes

NCT02256332 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-09-23

No results posted yet for this study

Summary

Effects of a plant based ingredient on blood glucose in Type II diabetes patients.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

Low dose plant based ingredient

Reference food with low dose of plant based ingredient

DIETARY_SUPPLEMENT

High dose plant based ingredient

Reference food with high dose of plant based ingredient

DIETARY_SUPPLEMENT

Reference food format

Reference food without plant-based ingredient

Sponsors & Collaborators

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Dr Ketul Modi, MBBS · Lambda Therapeutics Research Ltd (LTRL)

  • Dr Shrikant V Deshpande · Ashirwad Hospital and Research Centre, THANE , MAHARASHTRA

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02256332 on ClinicalTrials.gov